HER-2 S310F + HER-2 amplification
|
CRC
|
HER-2 S310F + HER-2 amplification
|
CRC
|
fam-trastuzumab deruxtecan-nxki Resistant: C4 – Case Studies
|
fam-trastuzumab deruxtecan-nxki Resistant: C4 – Case Studies
|
HER-2 S310F + HER-2 amplification
|
CRC
|
HER-2 S310F + HER-2 amplification
|
CRC
|
trastuzumab + lapatinib Sensitive: C4 – Case Studies
|
trastuzumab + lapatinib Sensitive: C4 – Case Studies
|